Lataa...
Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor Immunity
The combination of antiangiogenesis and chemotherapy regimens with cancer immunotherapy has the potential to synergistically boost antitumor immunity. Herein, we report the construction of two bioresponsive nanoparticles, namely, Podo-NP and CbP-NP, comprising prodrugs of podophyllotoxin (Podo) and...
Tallennettuna:
| Julkaisussa: | ACS Nano |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216770/ https://ncbi.nlm.nih.gov/pubmed/33347262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsnano.0c07132 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|